These Nasdaq-listed healthcare stocks beat Monday’s market gains

October 03, 2023 03:38 AM PDT | By Akanksha Vashisht
Follow us on Google News:


  • The Nasdaq Composite Index rose by 0.67% on Monday, while the Nasdaq Healthcare Index fell by 0.67%.
  • Spok Holdings Inc., a healthcare communications provider, gained 1.75% intraday at Monday’s close.
  • LeMaitre Vascular Inc., a medical equipment manufacturer, closed 1.25% higher on Monday.

On Monday, October 2, 2023, the broader market index, the S&P 500, displayed an ordinary performance through the day, rising by only 0.01% intraday. Alternatively, the Nasdaq Composite Index was 0.67% higher by the end of trade on Monday.

However, the Nasdaq Healthcare Index ended 1.18% lower through the day on Monday. Some of the biggest Nasdaq-listed gainers through the day were healthcare stocks.

ALSO READ: Two silver stocks to observe as the metal sector shines bright

With that, let us look at two Nasdaq-listed healthcare stocks that surpassed the benchmark Nasdaq Composite Index’s intraday gains on Monday:

Spok Holdings Inc. (NASDAQ: SPOK)

Spok Healthcare provides healthcare communications through its paging services and software solutions. Spok has a market cap of over US$289 million.

For Q2 2023, Spok’s net income was US$4.7 million, as compared to a net income of US$1.9 million in Q2 2022. The net income reflected diluted per share earnings of US$0.23 in Q2 2023.

The adjusted EBITDA was US$8.5 million in Q2 2023, an increase of 81.3% over the previous corresponding period.

Image Source: ©2023 Kalkine®; Data Source: Company Reports

Meanwhile, for the full year 2023, Spok expects its revenue to range from US$134.5 million to US$137.5 million and an adjusted EBITDA between US$25 million and US$28 million. SPOK also declared a dividend of US$0.3125 per share for the quarter. 

Based on Monday’s closing price of US$14.52, SPOK has a dividend yield of 8.61% and a P/E ratio of 8.17x. As per Monday’s close, SPOK gained 1.75% intraday and 76% YTD.

ALSO READ: CCI & CFG: Two financial sector stocks to watch

LeMaitre Vascular Inc. (NASDAQ: LMAT)

LeMaitre is a medical equipment manufacturer in the peripheral vascular disease industry. The company primarily produces products used in open vascular surgery.

The company’s sales for Q2 2023 were US$50.1 million, an increase of 19% over Q2 2022. The quarter’s operating income was US$9.5 million, an 8% adjusted y-o-y increase.

LMAT declared a dividend of US$0.14 per share of common stock for the quarter. The earnings per diluted share amounted to US$0.36, an increase of a massive 127% over the previous corresponding period.

Image Source: ©2023 Kalkine®; Data Source: Company Reports

LeMaitre expects to bring in sales worth US$46.5 million to US$48.9 million for Q3 2023. The operating income guidance for the period stands in the range of US$7.4 million to US$8.9 million. 

Based on Monday’s closing price of US$55.16, LMAT has a dividend yield of 1.02% and a P/E ratio of 48.19x. As at the close of trade on Monday, LMAT closed 1.25% higher on an intraday basis and 19.16% higher on a YTD basis.


The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.

Top Listed Companies